World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
154
Citations
78515
World Ranking
110
National Ranking
70

Medicine

D-Index
155
Citations
78920
World Ranking
976
National Ranking
560

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

James G. Krueger is a researcher affiliated with Rockefeller University in the United States. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Immunology and Dermatology as subfields. The research encompasses areas including Surgery, Oncology, and Physiology.

The scientist's main topics of investigation include:

  • Psoriasis: Treatment and Pathogenesis
  • Dermatology and Skin Diseases
  • Hidradenitis Suppurativa and Treatments
  • Asthma and respiratory diseases
  • Colorectal and Anal Carcinomas
  • Cytokine Signaling Pathways and Interactions
  • Allergic Rhinitis and Sensitization

James G. Krueger has contributed research articles published in several frequent academic venues, including:

  • Journal of Investigative Dermatology
  • Journal of the American Academy of Dermatology
  • British Journal of Dermatology
  • Journal of Allergy and Clinical Immunology
  • Allergy

Among their recent papers are:

  • Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis (2020, Journal of Allergy and Clinical Immunology)
  • Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial (2021, The Lancet)
  • Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis (2020, Journal of Allergy and Clinical Immunology)
  • The aging skin microenvironment dictates stem cell behavior (2020, Proceedings of the National Academy of Sciences)
  • Cardiovascular Risk in Patients With Psoriasis (2021, Journal of the American College of Cardiology)

Frequent co-authors collaborating with James G. Krueger include:

  • Sandra Garcet
  • Emma Guttman-Yassky
  • John W. Frew
  • Yeriel Estrada
  • Kristina Navrazhina

Best Publications

  • Pathogenesis and therapy of psoriasis

    Michelle A. Lowes;Anne M. Bowcock;James G. Krueger

  • Immunology of Psoriasis

    Michelle A Lowes;Mayte Suárez-Fariñas;James G Krueger

  • Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

    Michelle A. Lowes;Toyoko Kikuchi;Judilyn Fuentes-Duculan;Irma Cardinale

  • Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

    Kim A Papp;Craig Leonardi;Alan Menter;Jean-Paul Ortonne

  • Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

    Edmund Jd Lee;William L. Trepicchio;Judith L Oestreicher;Debra D Pittman

  • Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

    Rachel M. Grossman;James Krueger;Debra Yourish;Angela Granelli-Piperno

  • Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

    Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan

  • The immunologic basis for the treatment of psoriasis with new biologic agents

    James G. Krueger

  • Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

    K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan

  • Psoriasis pathogenesis and the development of novel targeted immune therapies

    Jason E. Hawkes;Tom C. Chan;James G. Krueger

  • Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

    Batya B. Davidovici;Naveed Sattar;Prinz C. Jörg;Luis Puig

  • Psoriasis pathophysiology: current concepts of pathogenesis

    J G Krueger;A Bowcock

  • Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism

    Youdong Pan;Tian Tian;Chang Ook Park;Serena Y. Lofftus

  • Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

    Lisa C. Zaba;Irma Cardinale;Patricia Gilleaudeau;Mary Sullivan-Whalen

  • CTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgaris

    Judith R. Abrams;Mark G. Lebwohl;Cynthia A. Guzzo;Brian V. Jegasothy

  • IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

    Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan

  • Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.

    Scott L. Gottlieb;Patricia Gilleaudeau;Ray Johnson;Len Estes

  • Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis

    Andrea Chiricozzi;Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Kristine E. Nograles

  • Getting under the skin: the immunogenetics of psoriasis

    Anne M. Bowcock;James G. Krueger

  • The immunogenetics of Psoriasis: A comprehensive review.

    Jamie L. Harden;James G. Krueger;Anne M. Bowcock

  • THE MAJORITY OF EPIDERMAL T CELLS IN PSORIASIS VULGARIS LESIONS CAN PRODUCE TYPE 1 CYTOKINES, INTERFERON-GAMMA, INTERLEUKIN-2, AND TUMOR NECROSIS FACTOR-ALPHA, DEFINING TC1 (CYTOTOXIC T LYMPHOCYTE) AND TH1 EFFECTOR POPULATIONS: A TYPE 1 DIFFERENTIATION BIAS IS ALSO MEASURED IN CIRCULATING BLOOD T CELLS IN PSORIATIC PATIENTS

    Lisa M. Austin;Maki Ozawa;Toyoko Kikuchi;Ian B. Walters

Frequent Co-Authors

Emma Guttman-Yassky
Emma Guttman-Yassky Icahn School of Medicine at Mount Sinai
Mayte Suárez-Fariñas
Mayte Suárez-Fariñas Icahn School of Medicine at Mount Sinai
Judilyn Fuentes-Duculan
Judilyn Fuentes-Duculan Rockefeller University
Michelle A. Lowes
Michelle A. Lowes Rockefeller University
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Kim Papp
Kim Papp Probity Medical Research
Jeffrey S. Berger
Jeffrey S. Berger New York University
Anne M. Bowcock
Anne M. Bowcock Icahn School of Medicine at Mount Sinai
Alan Menter
Alan Menter Texas A&M University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare professions, many of which offer flexible online learning options. For those interested in nursing, accelerated paths such as absn programs with high acceptance rates provide a quicker way to enter the field. These programs help students transition efficiently into nursing roles while maintaining rigorous standards.

For individuals looking to start their healthcare journey, lpn programs easy to get into offer accessible entry points. Licensed Practical Nurses play crucial roles in clinical settings that often collaborate with immunologists and other specialists.

Advanced practice nurses can expand their expertise through easiest online nurse practitioner programs. These programs are designed to accommodate working professionals looking to enhance their qualifications and career prospects.

Specifically, mental health-focused nursing roles are supported by some of the best online pmhnp programs with best clinical placement rates. These specialized pathways facilitate hands-on training combined with flexible online coursework, perfect for those aiming to integrate immunological insights into mental health practice.

Best Scientists Citing James G. Krueger

Trending Scientists